Covalon Technologies Ltd. (TSXV:COV)
1.890
-0.010 (-0.53%)
Apr 28, 2026, 2:15 PM EST
Covalon Technologies Market Cap
Covalon Technologies has a market cap or net worth of CAD 52.47 million as of April 28, 2026. Its market cap has decreased by -17.51% in one year.
Market Cap
52.47M
Enterprise Value
36.66M
Revenue
31.54M
Ranking
n/a
PE Ratio
55.28
Stock Price
1.89
Market Cap Chart
Since September 3, 2004, Covalon Technologies's market cap has increased from 3.06M to 52.47M, an increase of 1,613.34%. That is a compound annual growth rate of 14.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 52.20M | 9.41% |
| Dec 31, 2025 | 47.71M | -46.42% |
| Dec 31, 2024 | 89.04M | 240.51% |
| Dec 29, 2023 | 26.15M | -55.61% |
| Dec 30, 2022 | 58.91M | -14.07% |
| Dec 31, 2021 | 68.55M | 130.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.53B |
| Extendicare | 2.80B |
| Sienna Senior Living | 2.45B |
| Trulieve Cannabis | 2.29B |
| Sernova Biotherapeutics | 62.36M |
| Leef Brands | 59.90M |
| Rocket Doctor AI | 56.78M |
| NurExone Biologic | 54.31M |